Tanreqing injection inhibits dengue virus encephalitis by suppressing the activation of NLRP3 inflammasome

• Main Authors: Hefei Huang (Author), Xuemei He (Author), Lingzhu Shi (Author), Jingtao Yu (Author), Zibin Lu (Author), Huihui Cao (Author), Jinying Ou (Author), Xi Chen (Author), Lijun Yan (Author), Jiabin Yang (Author), Wei Zhao (Author), Junshan Liu (Author), Linzhong Yu (Author)
• Format: Book
• Published: BMC, 2024-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Encephalitis caused by dengue virus (DENV) is considered a manifestation of severe dengue. Tanreqing injection (TRQ) is a well-known Chinese patented medicine, which has been used to treat brain-related disorders by inhibiting inflammation. Nevertheless, the effects of TRQ on DEN...